{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:30:06Z","timestamp":1791729006597,"version":"4.3.4"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000334","name":"international spinal research trust","doi-asserted-by":"publisher","award":["NRB2015"],"award-info":[{"award-number":["NRB2015"]}],"id":[{"id":"10.13039\/501100000334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"medical research council","doi-asserted-by":"publisher","award":["MC-PC-15029"],"award-info":[{"award-number":["MC-PC-15029"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The serine protease inhibitor nafamostat has been proposed as a treatment for COVID-19, by inhibiting TMPRSS2-mediated viral cell entry. Nafamostat has been shown to have other, immunomodulatory effects, which may be beneficial for treatment, however animal models of ssRNA virus infection are lacking. In this study, we examined the potential of the dual TLR7\/8 agonist R848 to mimic the host response to an ssRNA virus infection and the associated behavioural response. In addition, we evaluated the anti-inflammatory effects of nafamostat in this model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CD-1 mice received an intraperitoneal injection of R848 (200\u00a0\u03bcg, prepared in DMSO, diluted 1:10 in saline) or diluted DMSO alone, and an intravenous injection of either nafamostat (100\u00a0\u03bcL, 3\u00a0mg\/kg in 5% dextrose) or 5% dextrose alone. Sickness behaviour was determined by temperature, food intake, sucrose preference test, open field and forced swim test. Blood and fresh liver, lung and brain were collected 6\u00a0h post-challenge to measure markers of peripheral and central inflammation by blood analysis, immunohistochemistry and qPCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>R848 induced a robust inflammatory response, as evidenced by increased expression of TNF, IFN-\u03b3, CXCL1 and CXCL10 in the liver, lung and brain, as well as a sickness behaviour phenotype. Exogenous administration of nafamostat suppressed the hepatic inflammatory response, significantly reducing TNF and IFN-\u03b3 expression, but had no effect on lung or brain cytokine production. R848 administration depleted circulating leukocytes, which was restored by nafamostat treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data indicate that R848 administration provides a useful model of ssRNA virus infection, which induces inflammation in the periphery and CNS, and virus infection-like illness. In turn, we show that nafamostat has a systemic anti-inflammatory effect in the presence of the TLR7\/8 agonist. Therefore, the results indicate that nafamostat has anti-inflammatory actions, beyond its ability to inhibit TMPRSS2, that might potentiate its anti-viral actions in pathologies such as COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-021-02357-y","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T11:02:38Z","timestamp":1641466958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness"],"prefix":"10.1186","volume":"19","author":[{"given":"Abi G.","family":"Yates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Weglinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel K.","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Strekalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-6655","authenticated-orcid":false,"given":"Daniel C.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"2357_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e278.","journal-title":"Cell"},{"issue":"6","key":"2357_CR2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/v12060629","volume":"12","author":"M Yamamoto","year":"2020","unstructured":"Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, et al. The anticoagulant nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner. Viruses. 2020;12(6):629.","journal-title":"Viruses"},{"key":"2357_CR3","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/AAC.01043-16","volume":"60","author":"M Yamamoto","year":"2016","unstructured":"Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrob Agents Chemother. 2016;60:6532\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2357_CR4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijid.2020.10.093","volume":"102","author":"W Takahashi","year":"2021","unstructured":"Takahashi W, Yoneda T, Koba H, Ueda T, Tsuji N, Ogawa H, Asakura H. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation. Int J Infect Dis. 2021;102:529\u201331.","journal-title":"Int J Infect Dis"},{"key":"2357_CR5","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1007\/s12035-016-9999-7","volume":"54","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li C, Wang J, Fang Y, Sun H, Tao X, Zhou XF, Liao H. Nafamostat mesilate improves neurological outcome and axonal regeneration after stroke in rats. Mol Neurobiol. 2017;54:4217\u201331.","journal-title":"Mol Neurobiol"},{"key":"2357_CR6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cns.12801","volume":"24","author":"HQ Duan","year":"2018","unstructured":"Duan HQ, Wu QL, Yao X, Fan BY, Shi HY, Zhao CX, Zhang Y, Li B, Sun C, Kong XH, et al. Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury. CNS Neurosci Ther. 2018;24:429\u201338.","journal-title":"CNS Neurosci Ther"},{"key":"2357_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02925610","volume":"16","author":"F Marotta","year":"1994","unstructured":"Marotta F, Fesce E, Rezakovic I, Chui DH, Suzuki K, Ideo G. Nafamostat mesilate on the course of acute pancreatitis. Protective effect on peritoneal permeability and relation with supervening pulmonary distress. Int J Pancreatol. 1994;16:51\u20139.","journal-title":"Int J Pancreatol"},{"key":"2357_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"YC Lu","year":"2008","unstructured":"Lu YC, Yeh WC, Ohashi PS. LPS\/TLR4 signal transduction pathway. Cytokine. 2008;42:145\u201351.","journal-title":"Cytokine"},{"key":"2357_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/NEN.0b013e3181654957","volume":"67","author":"SJ Campbell","year":"2008","unstructured":"Campbell SJ, Anthony DC, Oakley F, Carlsen H, Elsharkawy AM, Blomhoff R, Mann DA. Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain. J Neuropathol Exp Neurol. 2008;67:223\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2357_CR10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0002-9440(10)62365-6","volume":"166","author":"SJ Campbell","year":"2005","unstructured":"Campbell SJ, Perry VH, Pitossi FJ, Butchart AG, Chertoff M, Waters S, Dempster R, Anthony DC. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol. 2005;166:1487\u201397.","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"2357_CR11","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0889-1591(02)00077-6","volume":"17","author":"KW Kelley","year":"2003","unstructured":"Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17(Suppl 1):S112-118.","journal-title":"Brain Behav Immun"},{"key":"2357_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2012.12.017","volume":"29","author":"Y Couch","year":"2013","unstructured":"Couch Y, Anthony DC, Dolgov O, Revischin A, Festoff B, Santos AI, Steinbusch HW, Strekalova T. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun. 2013;29:136\u201346.","journal-title":"Brain Behav Immun"},{"key":"2357_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbi.2006.12.007","volume":"21","author":"C Cunningham","year":"2007","unstructured":"Cunningham C, Campion S, Teeling J, Felton L, Perry VH. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun. 2007;21:490\u2013502.","journal-title":"Brain Behav Immun"},{"key":"2357_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41419-018-0520-2","volume":"9","author":"M Monguio-Tortajada","year":"2018","unstructured":"Monguio-Tortajada M, Franquesa M, Sarrias MR, Borras FE. Low doses of LPS exacerbate the inflammatory response and trigger death on TLR3-primed human monocytes. Cell Death Dis. 2018;9:499.","journal-title":"Cell Death Dis"},{"key":"2357_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, Blomberg WR, Meigs DD, Hasan M, Patel M, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15:359\u201386.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2357_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","volume":"10","author":"CA Jefferies","year":"2019","unstructured":"Jefferies CA. Regulating IRFs in IFN driven disease. Front Immunol. 2019;10:325.","journal-title":"Front Immunol"},{"key":"2357_CR17","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3389\/fimmu.2019.02860","volume":"10","author":"L Pluta","year":"2019","unstructured":"Pluta L, Yousefi B, Damania B, Khan AA. Endosomal TLR-8 senses microRNA-1294 resulting in the production of NFkB dependent cytokines. Front Immunol. 2019;10:2860.","journal-title":"Front Immunol"},{"key":"2357_CR18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12026-016-8876-9","volume":"64","author":"DM Giraldo","year":"2016","unstructured":"Giraldo DM, Hernandez JC, Urcuqui-Inchima S. HIV-1-derived single-stranded RNA acts as activator of human neutrophils. Immunol Res. 2016;64:1185\u201394.","journal-title":"Immunol Res"},{"key":"2357_CR19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526\u20139.","journal-title":"Science"},{"key":"2357_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102295","volume":"24","author":"GR Campbell","year":"2021","unstructured":"Campbell GR, To RK, Hanna J, Spector SA. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway. iScience. 2021;24: 102295.","journal-title":"iScience"},{"key":"2357_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245924","volume":"16","author":"TR Karhadkar","year":"2021","unstructured":"Karhadkar TR, Pilling D, Gomer RH. Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. PLoS ONE. 2021;16: e0245924.","journal-title":"PLoS ONE"},{"key":"2357_CR22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbi.2019.09.004","volume":"82","author":"KA Michaelis","year":"2019","unstructured":"Michaelis KA, Norgard MA, Levasseur PR, Olson B, Burfeind KG, Buenafe AC, Zhu X, Jeng S, McWeeney SK, Marks DL. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance. Brain Behav Immun. 2019;82:338\u201353.","journal-title":"Brain Behav Immun"},{"key":"2357_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196\u2013200.","journal-title":"Nat Immunol"},{"key":"2357_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41385-020-0314-6","volume":"14","author":"S Makris","year":"2021","unstructured":"Makris S, Johansson C. R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice. Mucosal Immunol. 2021;14:267\u201376.","journal-title":"Mucosal Immunol"},{"key":"2357_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroscience.2011.11.013","volume":"201","author":"J Damm","year":"2012","unstructured":"Damm J, Wiegand F, Harden LM, Gerstberger R, Rummel C, Roth J. Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the Toll-like receptor 7 agonist imiquimod. Neuroscience. 2012;201:166\u201383.","journal-title":"Neuroscience"},{"key":"2357_CR26","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/srep05531","volume":"4","author":"T Chen","year":"2014","unstructured":"Chen T, Wang J, Li C, Zhang W, Zhang L, An L, Pang T, Shi X, Liao H. Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition. Sci Rep. 2014;4:5531.","journal-title":"Sci Rep"},{"key":"2357_CR27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijid.2020.05.072","volume":"96","author":"S Jang","year":"2020","unstructured":"Jang S, Rhee JY. Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy. Int J Infect Dis. 2020;96:500\u20132.","journal-title":"Int J Infect Dis"},{"key":"2357_CR28","volume":"12","author":"K Li","year":"2021","unstructured":"Li K, Meyerholz DK, Bartlett JA, McCray PB Jr. The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19. MBio. 2021;12: e0097021.","journal-title":"MBio"},{"key":"2357_CR29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-016-0572-0","volume":"13","author":"Y Couch","year":"2016","unstructured":"Couch Y, Trofimov A, Markova N, Nikolenko V, Steinbusch HW, Chekhonin V, Schroeter C, Lesch KP, Anthony DC, Strekalova T. Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice. J Neuroinflammation. 2016;13:108.","journal-title":"J Neuroinflammation"},{"key":"2357_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pbb.2018.05.011","volume":"178","author":"J Richetto","year":"2019","unstructured":"Richetto J, Polesel M, Weber-Stadlbauer U. Effects of light and dark phase testing on the investigation of behavioural paradigms in mice: relevance for behavioural neuroscience. Pharmacol Biochem Behav. 2019;178:19\u201329.","journal-title":"Pharmacol Biochem Behav"},{"key":"2357_CR31","doi-asserted-by":"crossref","first-page":"5098591","DOI":"10.1155\/2016\/5098591","volume":"2016","author":"T Strekalova","year":"2016","unstructured":"Strekalova T, Markova N, Shevtsova E, Zubareva O, Bakhmet A, Steinbusch HM, Bachurin S, Lesch KP. Individual differences in behavioural despair predict brain GSK-3beta expression in mice: the power of a modified swim test. Neural Plast. 2016;2016:5098591.","journal-title":"Neural Plast"},{"key":"2357_CR32","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1038\/s41598-020-74008-w","volume":"10","author":"SY Chan","year":"2020","unstructured":"Chan SY, Probert F, Radford-Smith DE, Hebert JC, Claridge TDW, Anthony DC, Burnet PWJ. Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites. Sci Rep. 2020;10:16857.","journal-title":"Sci Rep"},{"key":"2357_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbi.2015.10.007","volume":"52","author":"HM Savignac","year":"2016","unstructured":"Savignac HM, Couch Y, Stratford M, Bannerman DM, Tzortzis G, Anthony DC, Burnet PWJ. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-beta levels in male mice. Brain Behav Immun. 2016;52:120\u201331.","journal-title":"Brain Behav Immun"},{"key":"2357_CR34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","volume":"29","author":"R Dantzer","year":"2009","unstructured":"Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin N Am. 2009;29:247\u201364.","journal-title":"Immunol Allergy Clin N Am"},{"key":"2357_CR35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123\u201337.","journal-title":"Neurosci Biobehav Rev"},{"key":"2357_CR36","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1038\/s41598-017-09710-3","volume":"7","author":"Y Couch","year":"2017","unstructured":"Couch Y, Akbar N, Roodselaar J, Evans MC, Gardiner C, Sargent I, Romero IA, Bristow A, Buchan AM, Haughey N, Anthony DC. Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation. Sci Rep. 2017;7:9574.","journal-title":"Sci Rep"},{"key":"2357_CR37","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/IAI.05043-11","volume":"79","author":"JL Johnson","year":"2011","unstructured":"Johnson JL, Hong H, Monfregola J, Catz SD. Increased survival and reduced neutrophil infiltration of the liver in Rab27a- but not Munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. Infect Immun. 2011;79:3607\u201318.","journal-title":"Infect Immun"},{"key":"2357_CR38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1096\/fj.02-0757fje","volume":"17","author":"SJ Campbell","year":"2003","unstructured":"Campbell SJ, Hughes PM, Iredale JP, Wilcockson DC, Waters S, Docagne F, Perry VH, Anthony DC. CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 2003;17:1168\u201370.","journal-title":"FASEB J"},{"key":"2357_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.09.426034","author":"N McGarry","year":"2021","unstructured":"McGarry N, Murray CL, Garvey S, Wilkinson A, Tortorelli L, Ryan L, Hayden L, Healy D, Griffin EW, Hennessy E, et al. Double stranded RNA drives innate immune responses, sickness behavior and cognitive impairment dependent on dsRNA length, IFNAR1 expression and age. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.01.09.426034.","journal-title":"bioRxiv."},{"key":"2357_CR40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2018.06.014","volume":"323","author":"M Careaga","year":"2018","unstructured":"Careaga M, Taylor SL, Chang C, Chiang A, Ku KM, Berman RF, Van de Water JA, Bauman MD. Variability in PolyIC induced immune response: implications for preclinical maternal immune activation models. J Neuroimmunol. 2018;323:87\u201393.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"2357_CR41","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/jmv.27050","volume":"93","author":"L Han","year":"2021","unstructured":"Han L, Zhuang MW, Deng J, Zheng Y, Zhang J, Nan ML, Zhang XJ, Gao C, Wang PH. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J Med Virol. 2021;93(9):5376\u201389.","journal-title":"J Med Virol"},{"key":"2357_CR42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","volume":"22","author":"MA Moreno-Eutimio","year":"2020","unstructured":"Moreno-Eutimio MA, Lopez-Macias C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 2020;22:226\u20139.","journal-title":"Microbes Infect"},{"key":"2357_CR43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI van der Made","year":"2020","unstructured":"van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, van Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324:663\u201373.","journal-title":"JAMA"},{"key":"2357_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2018.12.002","volume":"99","author":"S Antoniuk","year":"2019","unstructured":"Antoniuk S, Bijata M, Ponimaskin E, Wlodarczyk J. Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability. Neurosci Biobehav Rev. 2019;99:101\u201316.","journal-title":"Neurosci Biobehav Rev"},{"key":"2357_CR45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/215668b0","volume":"215","author":"R Levine","year":"1967","unstructured":"Levine R. Genetic relationships, choice models, and sucrose preference behaviour in mice. Nature. 1967;215:668\u20139.","journal-title":"Nature"},{"key":"2357_CR46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pnpbp.2009.12.014","volume":"34","author":"T Strekalova","year":"2010","unstructured":"Strekalova T, Steinbusch HW. Measuring behavior in mice with chronic stress depression paradigm. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:348\u201361.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2357_CR47","volume":"10","author":"Y Couch","year":"2015","unstructured":"Couch Y, Xie Q, Lundberg L, Sharp T, Anthony DC. A model of post-infection fatigue is associated with increased TNF and 5-HT2A receptor expression in mice. PLoS ONE. 2015;10: e0130643.","journal-title":"PLoS ONE"},{"key":"2357_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112024","volume":"372","author":"S Munshi","year":"2019","unstructured":"Munshi S, Parrilli V, Rosenkranz JA. Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1beta-induced anxiety and sickness behaviors in adult male rats. Behav Brain Res. 2019;372: 112024.","journal-title":"Behav Brain Res"},{"key":"2357_CR49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.pbb.2007.02.010","volume":"86","author":"AH Swiergiel","year":"2007","unstructured":"Swiergiel AH, Dunn AJ. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav. 2007;86:651\u20139.","journal-title":"Pharmacol Biochem Behav"},{"key":"2357_CR50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0893-133X(00)00226-8","volume":"24","author":"R Yirmiya","year":"2001","unstructured":"Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology. 2001;24:531\u201344.","journal-title":"Neuropsychopharmacology"},{"key":"2357_CR51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12974-014-0178-3","volume":"11","author":"Y Couch","year":"2014","unstructured":"Couch Y, Davis AE, Sa-Pereira I, Campbell SJ, Anthony DC. Viral pre-challenge increases central nervous system inflammation after intracranial interleukin-1beta injection. J Neuroinflamm. 2014;11:178.","journal-title":"J Neuroinflamm"},{"key":"2357_CR52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-10-66","volume":"10","author":"M Maes","year":"2012","unstructured":"Maes M, Berk M, Goehler L, Song C, Anderson G, Galecki P, Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012;10:66.","journal-title":"BMC Med"},{"key":"2357_CR53","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbi.2010.01.011","volume":"24","author":"SJ Campbell","year":"2010","unstructured":"Campbell SJ, Meier U, Mardiguian S, Jiang Y, Littleton ET, Bristow A, Relton J, Connor TJ, Anthony DC. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain Behav Immun. 2010;24:738\u201346.","journal-title":"Brain Behav Immun"},{"key":"2357_CR54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2008.06.017","volume":"32","author":"Y Jiang","year":"2008","unstructured":"Jiang Y, Deacon R, Anthony DC, Campbell SJ. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol Dis. 2008;32:125\u201332.","journal-title":"Neurobiol Dis"},{"key":"2357_CR55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-8994-2_5","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The forced swim test for depression-like behavior in rodents. Methods Mol Biol. 2019;1916:75\u201380.","journal-title":"Methods Mol Biol"},{"key":"2357_CR56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2004.11.024","volume":"160","author":"T Deak","year":"2005","unstructured":"Deak T, Bellamy C, D\u2019Agostino LG, Rosanoff M, McElderry NK, Bordner KA. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav Brain Res. 2005;160:125\u201334.","journal-title":"Behav Brain Res"},{"key":"2357_CR57","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","volume":"8","author":"KG Commons","year":"2017","unstructured":"Commons KG, Cholanians AB, Babb JA, Ehlinger DG. The rodent forced swim test measures stress-coping strategy, not depression-like behavior. ACS Chem Neurosci. 2017;8:955\u201360.","journal-title":"ACS Chem Neurosci"},{"key":"2357_CR58","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMoa0904252","volume":"361","author":"R Perez-Padilla","year":"2009","unstructured":"Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680\u20139.","journal-title":"N Engl J Med"},{"key":"2357_CR59","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.4049\/jimmunol.1302992","volume":"192","author":"K Boonnak","year":"2014","unstructured":"Boonnak K, Vogel L, Feldmann F, Feldmann H, Legge KL, Subbarao K. Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells. J Immunol. 2014;192:5906\u201312.","journal-title":"J Immunol"},{"key":"2357_CR60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1086\/381535","volume":"189","author":"T Li","year":"2004","unstructured":"Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, Ma X, Fan H, Lu W, Xie J, et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis. 2004;189:648\u201351.","journal-title":"J Infect Dis"},{"key":"2357_CR61","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2005-01-0342","volume":"106","author":"M Gunzer","year":"2005","unstructured":"Gunzer M, Riemann H, Basoglu Y, Hillmer A, Weishaupt C, Balkow S, Benninghoff B, Ernst B, Steinert M, Scholzen T, et al. Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion. Blood. 2005;106:2424\u201332.","journal-title":"Blood"},{"key":"2357_CR62","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10875-012-9687-y","volume":"32","author":"H Perkins","year":"2012","unstructured":"Perkins H, Khodai T, Mechiche H, Colman P, Burden F, Laxton C, Horscroft N, Corey T, Rodrigues D, Rawal J, et al. Therapy with TLR7 agonists induces lymphopenia: correlating pharmacology to mechanism in a mouse model. J Clin Immunol. 2012;32:1082\u201392.","journal-title":"J Clin Immunol"},{"key":"2357_CR63","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620\u20139.","journal-title":"J Clin Invest"},{"key":"2357_CR64","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827.","journal-title":"Front Immunol"},{"key":"2357_CR65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043320","volume":"7","author":"H Hackstein","year":"2012","unstructured":"Hackstein H, Hagel N, Knoche A, Kranz S, Lohmeyer J, von Wulffen W, Kershaw O, Gruber AD, Bein G, Baal N. Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells. PLoS ONE. 2012;7: e43320.","journal-title":"PLoS ONE"},{"key":"2357_CR66","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/271359","volume":"2013","author":"S Biesmans","year":"2013","unstructured":"Biesmans S, Meert TF, Bouwknecht JA, Acton PD, Davoodi N, De Haes P, Kuijlaars J, Langlois X, Matthews LJ, Ver Donck L, et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediat Inflamm. 2013;2013: 271359.","journal-title":"Mediat Inflamm"},{"key":"2357_CR67","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Moller R, Jordan TX, Oishi K, Panis M, Sachs D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036\u201345.","journal-title":"Cell"},{"key":"2357_CR68","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201241","volume":"217","author":"B Israelow","year":"2020","unstructured":"Israelow B, Song E, Mao T, Lu P, Meir A, Liu F, Alfajaro MM, Wei J, Dong H, Homer RJ, et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J Exp Med. 2020;217: e20201241.","journal-title":"J Exp Med"},{"key":"2357_CR69","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001541","volume":"102","author":"T Alothaimeen","year":"2021","unstructured":"Alothaimeen T, Trus E, Basta S, Gee K. Differential TLR7-mediated cytokine expression by R848 in M-CSF- versus GM-CSF-derived macrophages after LCMV infection. J Gen Virol. 2021;102: 001541.","journal-title":"J Gen Virol"},{"key":"2357_CR70","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.neuropharm.2008.06.074","volume":"55","author":"SJ Campbell","year":"2008","unstructured":"Campbell SJ, Zahid I, Losey P, Law S, Jiang Y, Bilgen M, van Rooijen N, Morsali D, Davis AE, Anthony DC. Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord. Neuropharmacology. 2008;55:780\u20137.","journal-title":"Neuropharmacology"},{"key":"2357_CR71","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1074\/jbc.M112.342683","volume":"287","author":"X Han","year":"2012","unstructured":"Han X, Li X, Yue SC, Anandaiah A, Hashem F, Reinach PS, Koziel H, Tachado SD. Epigenetic regulation of tumor necrosis factor alpha (TNFalpha) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling. J Biol Chem. 2012;287:13778\u201386.","journal-title":"J Biol Chem"},{"key":"2357_CR72","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2217\/fvl.14.70","volume":"9","author":"MC Patel","year":"2014","unstructured":"Patel MC, Shirey KA, Pletneva LM, Boukhvalova MS, Garzino-Demo A, Vogel SN, Blanco JC. Novel drugs targeting Toll-like receptors for antiviral therapy. Future Virol. 2014;9:811\u201329.","journal-title":"Future Virol"},{"key":"2357_CR73","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-019-12657-w","volume":"10","author":"KA Michaelis","year":"2019","unstructured":"Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM, Burfeind KG, Olson B, Pelz KR, Angeles Ramos DM, et al. The TLR7\/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nat Commun. 2019;10:4682.","journal-title":"Nat Commun"},{"key":"2357_CR74","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4049\/jimmunol.1600497","volume":"197","author":"BC Holbrook","year":"2016","unstructured":"Holbrook BC, Kim JR, Blevins LK, Jorgensen MJ, Kock ND, D\u2019Agostino RB Jr, Aycock ST, Hadimani MB, King SB, Parks GD, Alexander-Miller MA. A novel R848-conjugated inactivated influenza virus vaccine is efficacious and safe in a neonate nonhuman primate model. J Immunol. 2016;197:555\u201364.","journal-title":"J Immunol"},{"key":"2357_CR75","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-241087","volume":"14","author":"L Tiwari","year":"2021","unstructured":"Tiwari L, Gupta P, Singh CM, Singh PK. Persistent positivity of SARS-CoV-2 nucleic acid in asymptomatic healthcare worker: infective virion or inactive nucleic acid? BMJ Case Rep. 2021;14: e241087.","journal-title":"BMJ Case Rep"},{"key":"2357_CR76","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/cid\/ciaa638","volume":"71","author":"J Bullard","year":"2020","unstructured":"Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, Boodman C, Bello A, Hedley A, Schiffman Z, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. 2020;71:2663\u20136.","journal-title":"Clin Infect Dis"},{"key":"2357_CR77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.550769","volume":"11","author":"M Ghiboub","year":"2020","unstructured":"Ghiboub M, Zhao J, Li Yim AYF, Schilderink R, Verseijden C, van Hamersveld PHP, Duarte JM, Hakvoort TBM, Admiraal I, Harker NR, et al. HDAC3 mediates the inflammatory response and LPS tolerance in human monocytes and macrophages. Front Immunol. 2020;11: 550769.","journal-title":"Front Immunol"},{"key":"2357_CR78","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yexmp.2012.09.014","volume":"93","author":"F Safavi","year":"2012","unstructured":"Safavi F, Rostami A. Role of serine proteases in inflammation: Bowman\u2013Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases. Exp Mol Pathol. 2012;93:428\u201333.","journal-title":"Exp Mol Pathol"},{"key":"2357_CR79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.molimm.2009.10.003","volume":"47","author":"T Burster","year":"2010","unstructured":"Burster T, Macmillan H, Hou T, Boehm BO, Mellins ED. Cathepsin G: roles in antigen presentation and beyond. Mol Immunol. 2010;47:658\u201365.","journal-title":"Mol Immunol"},{"key":"2357_CR80","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bst0280545","volume":"28","author":"RB Sim","year":"2000","unstructured":"Sim RB, Laich A. Serine proteases of the complement system. Biochem Soc Trans. 2000;28:545\u201350.","journal-title":"Biochem Soc Trans"},{"key":"2357_CR81","first-page":"249","volume":"3","author":"X Chen","year":"2011","unstructured":"Chen X, Li M, Xiong ZG, Orser BA, Macdonald JF, Lu WY. An anti-coagulation agent Futhan preferentially targets GABA(A) receptors in lung epithelia: implication in treating asthma. Int J Physiol Pathophysiol Pharmacol. 2011;3:249\u201356.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"2357_CR82","first-page":"767","volume":"27","author":"S Tsukagoshi","year":"2000","unstructured":"Tsukagoshi S. Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation. Gan To Kagaku Ryoho. 2000;27:767\u201374.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2357_CR83","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1471-4159.2007.04928.x","volume":"103","author":"SJ Campbell","year":"2007","unstructured":"Campbell SJ, Jiang Y, Davis AE, Farrands R, Holbrook J, Leppert D, Anthony DC. Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J Neurochem. 2007;103:2245\u201355.","journal-title":"J Neurochem"},{"key":"2357_CR84","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(20)30218-0","volume":"7","author":"T Kander","year":"2020","unstructured":"Kander T. Coagulation disorder in COVID-19. Lancet Haematol. 2020;7:e630\u20132.","journal-title":"Lancet Haematol"},{"key":"2357_CR85","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","volume":"7","author":"D Liao","year":"2020","unstructured":"Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, Gao Y, Cai L, Wang Z, Yin P, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7:e671\u20138.","journal-title":"Lancet Haematol"},{"key":"2357_CR86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-020-03029-y","volume":"113","author":"H Asakura","year":"2021","unstructured":"Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113:45\u201357.","journal-title":"Int J Hematol"},{"issue":"1","key":"2357_CR87","volume":"7","author":"S Doi","year":"2020","unstructured":"Doi S, Akashi YJ, Takita M, Yoshida H, Morikawa D, Ishibashi Y, Higuma T, Fujitani S. Preventing thrombosis in a COVID-19 patient by combinatorial therapy with nafamostat and heparin during extracorporeal membrane oxygenation. Acute Med Surg. 2020;7(1): e585.","journal-title":"Acute Med Surg"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02357-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02357-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02357-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T11:10:51Z","timestamp":1641467451000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02357-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2357"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02357-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-628384\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the University of Oxford local committees (LERP, ACER) in accordance with the UK Animals (Scientific Procedures) Act 1989.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}